Notably, overexpression of AP2 also significantly enhanced the proliferation of USP22-WT H1299 (upper panel) and A549 (lower panel), but not in USP22-KO H1299 and A549 cancer cells (Fig. 6B). Here, TFAP2A is linked to cancer.